Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05845801

Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer

The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

PDAC - Pancreatic Ductal Adenocarcinoma

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≤55 years old at the time of diagnosis of pancreatic cancer
  • Age ≥ 18 years
  • Written informed consent obtained.

Exclusion criteria

  • Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
  • Absence of informed consent.
  • Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer

Treatment and study plan

register

Other

Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.

Primary outcomes

  1. Register of young PDAC patients

    Time frame: 30 years

    Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.

Study contacts

Contact information is provided by the study sponsor or research team.

Fabio Casciani

CONTACT

[email protected]

0458124671

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Other

Registry information

Acronym: PanC-YOUNG

Important dates

Study start
2022
Primary completion
2052
Study completion
2052
First posted
May 6, 2023
Registry last updated
May 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.